Cytoreductive Surgery Plus Hyperthermic Perioperative Chemotherapy for Selected Patients with Peritoneal Metastases from Colorectal Cancer: A New Standard of Care or an Experimental Approach?
Peritoneal metastases (PM) are a common presentation for patients with metastatic colorectal cancer (CRC), and the median survival of patients with PM is approximately one year. In a majority of patients, the disease remains limited to the peritoneal cavity. Therefore, investigators have applied cyt...
Saved in:
| Main Author: | Paul H. Sugarbaker |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Gastroenterology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2012/309417 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in the Treatment of Colorectal Cancer with Peritoneal
Metastases: A Focus on Cytoreductive Surgery and Hyperthermic Intraperitoneal
Chemotherapy
by: Youngbae Jeon, et al.
Published: (2023-12-01) -
Overall survival post secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent colorectal cancer with peritoneal metastases
by: Raymond Hayler, et al.
Published: (2025-07-01) -
Peritoneal Dissemination of Hepatoid Carcinoma of the Ovary Treated with Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy
by: Pedro Antonio Cascales Campos, et al.
Published: (2013-01-01) -
Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy for Management of Peritoneal Sarcomatosis: A Preliminary Single-Center Experience from Saudi Arabia
by: Ahmed Abu-Zaid, et al.
Published: (2016-01-01) -
Pulmonary Complications following Cytoreductive Surgery and Perioperative Chemotherapy in 147 Consecutive Patients
by: Vinicius Preti, et al.
Published: (2012-01-01)